Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Boothman AM"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
Autorzy:
Dalvi T; AstraZeneca, One MedImmune Way, Gaithersburg, Maryland, United States of America.
Nørgaard M; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.
Fryzek JP; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.; EpidStrategies, Rockville, Maryland, United States of America.
Movva N; EpidStrategies, Rockville, Maryland, United States of America.
Pedersen L; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.
Pham Hansen H; Institute of Pathology, Aarhus University Hospital, Aarhus N, Denmark.
Walker J; AstraZeneca, Cambridge, United Kingdom.
Midha A; AstraZeneca, Cambridge, United Kingdom.
Shire N; AstraZeneca, One MedImmune Way, Gaithersburg, Maryland, United States of America.
Boothman AM; AstraZeneca, Cambridge, United Kingdom.
Rigas J; AstraZeneca, One MedImmune Way, Gaithersburg, Maryland, United States of America.
Mellemgaard A; AstraZeneca, Cambridge, United Kingdom.; Department of Oncology, Bornholm Hospital, Rønne, Denmark.
Rasmussen TR; Dansk Lunge Cancer Gruppe, Odense, Denmark.; Department of Respiratory Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Hamilton-Dutoit S; Institute of Pathology, Aarhus University Hospital, Aarhus N, Denmark.
Cronin-Fenton D; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus N, Denmark.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 11; Vol. 18 (4), pp. e0284037. Date of Electronic Publication: 2023 Apr 11 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Humans ; B7-H1 Antigen/metabolism ; Proto-Oncogene Proteins p21(ras)/metabolism ; Biomarkers, Tumor ; ErbB Receptors/metabolism ; Denmark
Czasopismo naukowe
Tytuł:
Analytical Validation and Clinical Utility of an Immunohistochemical Programmed Death Ligand-1 Diagnostic Assay and Combined Tumor and Immune Cell Scoring Algorithm for Durvalumab in Urothelial Carcinoma.
Autorzy:
Zajac M; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Boothman AM; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Ben Y; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Gupta A; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Jin X; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Mistry A; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Sabalos C; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Nielsen A; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Manriquez G; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Barker C; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Antal J; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Wang P; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Patil P; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Schechter N; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Rebelatto MC; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Walker J; From Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom (Drs Zajac, Boothman, and Walker and Mr Barker); Global Medicines Development, AstraZeneca, Gaithersburg, Maryland (Dr Ben); Clinical Development (Dr Gupta and Ms Antal), Biostatistics (Dr Jin), and Translational Sciences and Pathology (Dr Rebelatto), MedImmune, Gaithersburg, Maryland; and Roche Tissue Diagnostics, Ventana Medical Systems Inc, Tucson, Arizona (Drs Mistry, Manriquez, and Patil, Mr Sabalos, and Mss Nielsen, Wang, and Schechter). Dr Ben is currently affiliated with BioAtla, San Diego, California. Dr Jin is currently affiliated with Akeso Biopharma Inc, Zhongshan, Guangdong, China. Ms Antal is currently affiliated with G1 Therapeutics Inc, Research Triangle Park, North Carolina.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2019 Jun; Vol. 143 (6), pp. 722-731. Date of Electronic Publication: 2018 Nov 20.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Validation Study
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
B7-H1 Antigen/*analysis
Carcinoma, Transitional Cell/*drug therapy
Immunohistochemistry/*methods
Urinary Bladder Neoplasms/*drug therapy
Adult ; Algorithms ; Carcinoma, Transitional Cell/metabolism ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Urinary Bladder Neoplasms/metabolism
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies